CD8A and non-small cell lung carcinoma: Additionally, exosomal circUSP7 derived from tumor cells induces CD8+ T cell dysfunction and confers resistance to anti-PD-1 therapy in NSCLC via the miR-934/SHP2 axis (Chen S. W. et al., 2021).